A decrease in RCAN3 expression in renal clear cell carcinoma and renal papillary cell carcinoma may be due to the presence of other compensatory mechanisms or alternative pathways that reduce RCAN3-dependent signal regulation. This evidence concerns the gene RCAN3 and papillary renal cell carcinoma.